Immunocore Holdings (Immunocore Holdings) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Days Payable?

Immunocore Holdings's average Accounts Payable for the three months ended in Dec. 2023 was $18.2 Mil. Immunocore Holdings's Cost of Goods Sold for the three months ended in Dec. 2023 was $-0.3 Mil.

The historical rank and industry rank for Immunocore Holdings's Days Payable or its related term are showing as below:

IMCR' s Days Payable Range Over the Past 10 Years
Min: 3708.31 Med: 4679.12 Max: 5649.92
Current: 4684.94

During the past 6 years, Immunocore Holdings's highest Days Payable was 5649.92. The lowest was 3708.31. And the median was 4679.12.

IMCR's Days Payable is ranked better than
93.16% of 716 companies
in the Biotechnology industry
Industry Median: 148.12 vs IMCR: 4684.94

Immunocore Holdings's Days Payable declined from Dec. 2022 (1,457.43) to Dec. 2023 (0.00). It may suggest that Immunocore Holdings accelerated paying its suppliers.

Immunocore Holdings Days Payable Historical Data

The historical data trend for Immunocore Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Days Payable Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

3,794.79

5,577.72

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial														1,457.43	6,109.95	1,182.13	5,268.10	-

Competitive Comparison of Immunocore Holdings's Days Payable

For the Biotechnology subindustry, Immunocore Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunocore Holdings's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunocore Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Immunocore Holdings's Days Payable falls into.

Immunocore Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Immunocore Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (17.6	+	22.529)	/	2 )	/	1.313	*	365
=	20.0645					/	1.313	*	365
=	5,577.72

Immunocore Holdings's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (13.855	+	22.529)	/	2 )	/	-0.31299999999999	*	365 / 4
=	18.192					/	-0.31299999999999	*	365 / 4
=	N/A

Immunocore Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.